Mouwasat Medical Services Company (TADAWUL:4002)
60.25
+0.25 (0.42%)
Jul 23, 2026, 3:19 PM AST
TADAWUL:4002 Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, TADAWUL:4002 stock has a consensus rating of "Buy" and an average price target of SAR 84.94. The average 1-year stock price forecast is 40.98% higher than the current stock price, while the lowest is SAR 63.00 (+4.56%) and the highest is SAR 118.00 (+95.85%).
Price Target: SAR 84.94 (+40.98%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4002 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 5 | 5 | 6 | 6 |
| Buy | 1 | 1 | 1 | 0 | 1 | 1 |
| Hold | 5 | 6 | 5 | 6 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
3.62B
from 3.22B
Increased by 12.23%
Revenue Next Year
4.00B
from 3.62B
Increased by 10.54%
EPS This Year
4.26
from 4.11
Increased by 3.64%
EPS Next Year
4.50
from 4.26
Increased by 5.53%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.